, Heron Therapeutics Inc (NASDAQ:HRTX)’s traded shares were 0.48 million, with the beta value of the company hitting 1.80. The 52-week high for the HRTX share is $3.93, that puts it down -15.25 from that peak though still a striking 85.34% gain since the share price plummeted to a 52-week low of $0.50. The company’s market capitalization is $513.72M, and the average trade volume was 2.11 million shares over the past three months.
Heron Therapeutics Inc (NASDAQ:HRTX) trade information
The stock’s 5-day price performance is 5.57%, and it has moved by 4.28% in 30 days. Based on these gigs, the overall price performance for the year is 187.76%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Heron Therapeutics Inc (HRTX) estimates and forecasts
Statistics show that Heron Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Heron Therapeutics Inc (HRTX) shares have gone up 104.19% during the last six months, with a year-to-date growth rate more than the industry average at 87.50% against 13.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 20.01%. While earnings are projected to return 85.89% in 2024, the next five years will return 47.50% per annum.
HRTX Dividends
Heron Therapeutics Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
